Sublingual Fentanyl for the Management of Breakthrough Pain
Clinical trial NCT02514252 · TERMINATED
Trial details
- NCT number
- NCT02514252
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-02
- Primary completion
- 2019-11-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.